We support your R&D activities through:
-
Development and characterization of your NHP disease models
-
Preclinical evaluation of potential therapeutic candidates prior to clinical trials
-
AAALAC International standards for animal care
Our Team
CEO Message:
"Hamamatsu Laboratory is a contract research organization specializing in non-clinical efficacy and pharmacology testing.
In recent years, discrepancies between non-clinical and clinical trial results have become a challenge in new drug development, increasing the importance of translational research.
With the rapid growth of the biopharmaceutical market and accelerated outsourcing by pharmaceutical companies, demand is rising for verification of new drug candidates using cynomolgus monkeys, which are physiologically similar to humans.
Utilizing our unique technologies and advanced research, we aim to provide high-precision testing and competitive disease models, striving to become a research institute chosen by pharmaceutical companies worldwide."
Our History
2005
Founding of Hamamatsu Pharma Research, Inc, Japan
CEO Hiroyuki Takamatsu, PhD
2013
Primate Center established
2010
Head office / Central Research Facility established
2015
Accreditation by AAALAC International
2021
Signa Explorer 1.5T (GE Healthcare) on-line at HPR, Japan
2022
CEO Takahiro Natsume, PhD
Our History
2005
Founding of Hamamatsu Pharma Research, Inc, Japan
CEO Hiroyuki Takamatsu, PhD
2013
Primate Center established
2010
Head office / Central Research Facility established
2015
Accreditation by AAALAC International
2021
Signa Explorer 1.5T (GE Healthcare) on-line at HPR, Japan
CEO Takahiro Natsume, PhD
Our History
2005
Founding of Hamamatsu Pharma Research, Inc, Japan
CEO Hiroyuki Takamatsu, PhD
2013
Primate Center established
2010
Head office / Central Research Facility established
2015
Accreditation by AAALAC International
2021
Signa Explorer 1.5T (GE Healthcare) on-line at HPR, Japan
CEO Takahiro Natsume, PhD
2022
2023
HPR has joined as a subsidiary company of CMIC HOLDINGS Co., Ltd.
Our History
2005
Founding of Hamamatsu Pharma Research, Inc, Japan
CEO Hiroyuki Takamatsu, PhD
2013
Primate Center established
2010
Head office / Central Research Facility established
2015
Accreditation by AAALAC International
2021
Signa Explorer 1.5T (GE Healthcare) on-line at HPR, Japan
CEO Takahiro Natsume, PhD
2022
2023
HPR has joined as a subsidiary company of CMIC HOLDINGS Co., Ltd.
Our History
2005
Founding of Hamamatsu Pharma Research, Inc, Japan
CEO Hiroyuki Takamatsu, PhD
2013
Primate Center established
2010
Head office / Central Research Facility established
2015
Accreditation by AAALAC International
2021
Signa Explorer 1.5T (GE Healthcare) on-line at HPR, Japan
CEO Takahiro Natsume, PhD
2022
2023
HPR joins as a subsidiary of CMIC Holdings Co., Ltd.
2026
HPR absorbed into CMIC Pharma Science Co., Ltd.
Our Facilities
-
All studies are reviewed and approved by the Hamamatsu Laboratory Animal Care and Use Committee.
-
Animal care and housing in accordance with the "Guide for Care ad Use of Laboratory Animals" (Institute for Laboratory Animal Research, 2011)
-
Hamamatsu Laboratory is located in Hamamatsu, Japan.
Primate Center
-
8 holding rooms (up to 300 macaques)
-
4 procedure rooms
Central Research Facility
-
1 drug preparation room
-
1 cell culture room
Imaging Center
-
MRI room
Ophthalmology examination
Blood chemistry analysis
Pharmacological study room
HPR publication